Dhakal, B., Iida, S., Sidiqi, M. H., Zamagni, E., Yoon, S., Callander, N., Touzeau, C., Li, Q., Balogh, A., Slaughter, A., Benachour, N., Lonardi, C., Ghosh, A., Vogel, M., Lendvai, N., Lengil, T., Koneru, M., Patel, N., Costa, O., Mahajan, V., Martínez-López, J., Yong, K., Weisel, K., Leleu, X. (2025). Effectiveness of bridging therapy corresponds to improved outcomes after ciltacabtagene autoleucel: Phase 3 CARTITUDE-4 study of patients with relapsed, lenalidomide-refractory multiple myeloma. Blood. https://doi.org/10.1182/blood-2025-2215